Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile. - Burban A; Tessier C; Larroquette M; Guyon J; Lubiato C; Pinglaut M; Toujas M; Galvis J; Dartigues B; Georget E; Luchman HA; Weiss S; et al. (EMBO molecular medicine, 2025)